NHS National Diabetes Prevention Programme (NDPP)

NHS England is the operational name for the NHS Commissioning Board. NHS England is responsible for the direct commissioning of some health care services in England and for the oversight of the role of Clinical Commissioning Groups.

NHS England is currently working in partnership with Public Health England with support from Diabetes UK to establish a national programme to prevent and postpone the onset of Type 2 diabetes in identified high risk individuals. The programme is to be known as the NHS Diabetes Prevention Programme (NDPP).

The NDPP aims to deliver, at a large scale, services which identify people with non-diabetic hyperglycaemia who are at high risk of developing Type 2 diabetes and offer them a behavioural intervention to reduce their weight and increase physical activity. The NDPP has three distinct phases which have been designed to develop the evidence in a staged way and to enable checks and balances to be built into the NDPP as it is implemented: • Pre-procurement phase: work with seven demonstrator sites to test implementation of the NDPP.

This phase is already underway and will be completed in 2015/16; • Phase 1 Procurement 2015/16 to go live 2016/17: between 10,000 and 30,000 behavioural interventions across England are identified; and • Phase 2 Procurement in 2016 to go live 2017/18: will aim to deliver long-term contracts providing for incremental scaling up of services with a view to full coverage across England by 2019/20 (subject to final decisions about the pace of implementation). This Prior Information Notice, that is not being used as a call for competition, relates to the Phase 1 Procurement.

In order to gauge market interest in these opportunities, NHS England is seeking views from potential providers and other stakeholders in the NDPP to ensure maximum market engagement. This market engagement will take place until the 7th Sept 2015.